BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 16497246)

  • 1. Augmentation of osteopontin expression in renal tubuli is independent of a histopathological type of glomerular lesions in mouse lupus nephritis.
    Sasaki Y; Yamamoto Y; Miyazaki T; Ito MR; Nose M; Watanabe M
    Pathol Int; 2006 Mar; 56(3):135-43. PubMed ID: 16497246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fractalkine expression and CD16+ monocyte accumulation in glomerular lesions: association with their severity and diversity in lupus models.
    Nakatani K; Yoshimoto S; Iwano M; Asai O; Samejima K; Sakan H; Terada M; Hasegawa H; Nose M; Saito Y
    Am J Physiol Renal Physiol; 2010 Jul; 299(1):F207-16. PubMed ID: 20410215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implication of allelic polymorphism of osteopontin in the development of lupus nephritis in MRL/lpr mice.
    Miyazaki T; Ono M; Qu WM; Zhang MC; Mori S; Nakatsuru S; Nakamura Y; Sawasaki T; Endo Y; Nose M
    Eur J Immunol; 2005 May; 35(5):1510-20. PubMed ID: 15832294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial adhesion molecules in glomerular lesions: association with their severity and diversity in lupus models.
    Nakatani K; Fujii H; Hasegawa H; Terada M; Arita N; Ito MR; Ono M; Takahashi S; Saiga K; Yoshimoto S; Iwano M; Shiiki H; Saito Y; Nose M
    Kidney Int; 2004 Apr; 65(4):1290-300. PubMed ID: 15086468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of different types of glomerulonephritis by monoclonal antibodies derived from an MRL/lpr lupus mouse.
    Itoh J; Nose M; Takahashi S; Ono M; Terasaki S; Kondoh E; Kyogoku M
    Am J Pathol; 1993 Nov; 143(5):1436-43. PubMed ID: 8238259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between E-selectin expression and histopathological modification of glomerular lesions by non-nephritogenic IgM antibodies in experimental lupus nephritis.
    Nakatani K; Asai O; Sakan H; Yoshimoto S; Terada M; Nose M; Iwano M; Konishi N
    Mod Rheumatol; 2014 Sep; 24(5):808-15. PubMed ID: 24372297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel and enhanced IL-1 gene expression in autoimmune mice with lupus.
    Boswell JM; Yui MA; Endres S; Burt DW; Kelley VE
    J Immunol; 1988 Jul; 141(1):118-24. PubMed ID: 3259964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of glomerular heparan sulphate domains in murine and human lupus nephritis.
    Rops AL; van den Hoven MJ; Bakker MA; Lensen JF; Wijnhoven TJ; van den Heuvel LP; van Kuppevelt TH; van der Vlag J; Berden JH
    Nephrol Dial Transplant; 2007 Jul; 22(7):1891-902. PubMed ID: 17550924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced osteopontin expression and macrophage infiltration in MRL-Fas(lpr) mice with lupus nephritis.
    Wüthrich RP; Fan X; Ritthaler T; Sibalic V; Yu DJ; Loffing J; Kaissling B
    Autoimmunity; 1998; 28(3):139-50. PubMed ID: 9867126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of renal tubular epithelial cell-derived interleukin-18 up-regulation with disease activity in MRL-Faslpr mice with autoimmune lupus nephritis.
    Faust J; Menke J; Kriegsmann J; Kelley VR; Mayet WJ; Galle PR; Schwarting A
    Arthritis Rheum; 2002 Nov; 46(11):3083-95. PubMed ID: 12428253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental lupus nephritis in severe combined immunodeficient (SCID) mice: remodelling of the glomerular lesions by bystander IgM antibodies.
    Ito MR; Terasaki S; Kondo E; Shiwaku H; Fukuoka Y; Nose M
    Clin Exp Immunol; 2000 Feb; 119(2):340-5. PubMed ID: 10632673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneity of osteopontin expression among nephrons in mouse kidneys and enhanced expression in sclerotic glomeruli.
    Lopez CA; Hoyer JR; Wilson PD; Waterhouse P; Denhardt DT
    Lab Invest; 1993 Sep; 69(3):355-63. PubMed ID: 8377476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemokine receptor Ccr2 deficiency reduces renal disease and prolongs survival in MRL/lpr lupus-prone mice.
    Pérez de Lema G; Maier H; Franz TJ; Escribese M; Chilla S; Segerer S; Camarasa N; Schmid H; Banas B; Kalaydjiev S; Busch DH; Pfeffer K; Mampaso F; Schlöndorff D; Luckow B
    J Am Soc Nephrol; 2005 Dec; 16(12):3592-601. PubMed ID: 16267157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cloning and cDNA sequence analysis of nephritogenic monoclonal antibodies derived from an MRL/lpr lupus mouse.
    Takahashi S; Itoh J; Nose M; Ono M; Yamamoto T; Kyogoku M
    Mol Immunol; 1993 Feb; 30(2):177-82. PubMed ID: 8429833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Internalization of antibodies by endothelial cells via fibronectin implicating a novel mechanism in lupus nephritis.
    Fujii H; Nakatani K; Arita N; Ito MR; Terada M; Miyazaki T; Yoshida M; Ono M; Fujiwara T; Saiga K; Ota T; Ohtani H; Lockwood M; Sasaki T; Nose M
    Kidney Int; 2003 Nov; 64(5):1662-70. PubMed ID: 14531798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CXCR3 mediates renal Th1 and Th17 immune response in murine lupus nephritis.
    Steinmetz OM; Turner JE; Paust HJ; Lindner M; Peters A; Heiss K; Velden J; Hopfer H; Fehr S; Krieger T; Meyer-Schwesinger C; Meyer TN; Helmchen U; Mittrücker HW; Stahl RA; Panzer U
    J Immunol; 2009 Oct; 183(7):4693-704. PubMed ID: 19734217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteopontin as an injury marker expressing in epithelial hyperplasia lesions helpful in prognosis of focal segmental glomerulosclerosis.
    Shui HA; Ka SM; Yang SM; Lin YF; Lo YF; Chen A
    Transl Res; 2007 Oct; 150(4):216-22. PubMed ID: 17900509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular cloning and expression of a novel peptide (LN1) gene: reduced expression in the renal cortex of lupus nephritis in MRL/lpr mouse.
    Iwano M; Ueno S; Miyazaki M; Harada T; Nagai Y; Hirano M; Dohi Y; Akai Y; Kurioka H; Dohi K
    Biochem Biophys Res Commun; 1996 Dec; 229(1):355-60. PubMed ID: 8954131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antagonist of fractalkine (CX3CL1) delays the initiation and ameliorates the progression of lupus nephritis in MRL/lpr mice.
    Inoue A; Hasegawa H; Kohno M; Ito MR; Terada M; Imai T; Yoshie O; Nose M; Fujita S
    Arthritis Rheum; 2005 May; 52(5):1522-33. PubMed ID: 15880599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antagonist of monocyte chemoattractant protein 1 ameliorates the initiation and progression of lupus nephritis and renal vasculitis in MRL/lpr mice.
    Hasegawa H; Kohno M; Sasaki M; Inoue A; Ito MR; Terada M; Hieshima K; Maruyama H; Miyazaki J; Yoshie O; Nose M; Fujita S
    Arthritis Rheum; 2003 Sep; 48(9):2555-66. PubMed ID: 13130475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.